February 3, 2022
A younger age, the presence of comorbidities, and female sex are all factors associated with an increased risk for COVID-19 in patients with multiple sclerosis (MS), […]
February 3, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Fatigue imposes a significant […]
February 1, 2022
Native American tribes have reached settlements over the toll of opioids totaling $590 million with drugmaker Johnson & Johnson and the country’s three largest drug distribution […]
January 31, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Higher genetic risk of […]
January 31, 2022
It all started with genetic data. A gene here, a gene there. Eventually the story became clearer: If scientists are to one day find a cure […]
January 28, 2022
The newly approved insomnia drug daridorexant (Quviviq) improves sleep onset in adults, new phase 3 data suggest. In the first of two studies, a 50-mg […]
January 28, 2022
The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways Secondary injury to brain […]
January 28, 2022
Electrical brain stimulation may have the potential to improve verbal memory, results of a small study of patients with epilepsy suggest. Investigators observed improvements in patients […]
January 27, 2022
Subclinical changes in cardiac structure and diastolic function in early adulthood may serve as risk markers for cognitive decline in midlife, new research suggests. Cardiovascular disease […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141
Next page